SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
1-Year Return
18.59%
This Quarter Return
+20.08%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.37B
AUM Growth
+$183M
(+8.4%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-7.51%
Top 10 Holdings %
Top 10 Hldgs %
42.39%
Holding
113
New
23
Increased
16
Reduced
30
Closed
11
Top Buys
| 1 |
Coca-Cola
KO
|
$33.4M |
| 2 |
Apple
AAPL
|
$30.3M |
| 3 |
CRH
CRH
|
$28.9M |
| 4 |
ArriVent BioPharma
AVBP
|
$27.9M |
| 5 |
argenx
ARGX
|
$26.9M |
Top Sells
| 1 |
Arcellx
ACLX
|
$60.8M |
| 2 |
Royalty Pharma
RPRX
|
$49.7M |
| 3 |
Las Vegas Sands
LVS
|
$36.3M |
| 4 |
Microsoft
MSFT
|
$34.8M |
| 5 |
Biohaven
BHVN
|
$31.2M |
Sector Composition
| 1 | Healthcare | 65.84% |
| 2 | Technology | 8.92% |
| 3 | Communication Services | 8% |
| 4 | Consumer Discretionary | 5.07% |
| 5 | Financials | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
AnaptysBio
ANAB
$608M
| – | – |
-354,872
| Closed | -$7.6M |
|
102
AstraZeneca
AZN
$254B
| – | – |
-70,490
| Closed | -$4.75M |
|
103
Idexx Laboratories
IDXX
$51.1B
| – | – |
-920
| Closed | -$511K |
|
104
Incyte
INCY
$16.8B
| – | – |
-37,600
| Closed | -$2.36M |
|
105
KraneShares CSI China Internet ETF
KWEB
$8.43B
| – | – |
0
| – | – |
|
|
106
Las Vegas Sands
LVS
$37.7B
| – | – |
-738,163
| Closed | -$36.3M |
|
107
Merck
MRK
$209B
| – | – |
-15,500
| Closed | -$1.69M |
|
108
Pfizer
PFE
$140B
| – | – |
-50,300
| Closed | -$1.45M |
|
109
Invesco QQQ Trust
QQQ
$365B
| – | – |
0
| – | – |
|
110
Sana Biotechnology
SANA
$731M
| – | – |
-1,606,056
| Closed | -$6.55M |
|
111
SPDR S&P 500 ETF Trust
SPY
$659B
| – | – |
0
| – | – |
|
112
Bio-Techne
TECH
$8.11B
| – | – |
-2,600
| Closed | -$201K |
|
113
United Therapeutics
UTHR
$17.4B
| – | – |
-1,360
| Closed | -$299K |
|